ZOLL Medical Corporation (ZOLL, the Company, we or us) develops, manufactures, and markets resuscitation devices, related data management and software solutions, and temperature management technology. ZOLL is continuing its expansion from its founding focus on external pacemakers and defibrillators for the treatment of cardiac arrest to a much broader focus on a range of resuscitation devices and temperature management solutions for critical care and surgical patients. This expanded focus involves not only initial care but prevention of sudden cardiac death in patients with a known risk, as well as care after an event, where initial resuscitation success can be enhanced with specific strategies for improving recovery and reducing morbidity. As the science of resuscitation continues to expand, so does our business opportunity and the potential for revenue growth. We believe there is a substantially greater opportunity to improve operating profitability and achieve significant recurring revenues as we provide products and services to a much larger resuscitation and critical care market.
Company profile
Ticker
ZOLL
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
Zoll Medical Corporation
SEC CIK
Corporate docs
IRS number
42711626
Latest filings (excl ownership)
15-12G
Securities registration termination
7 May 12
EFFECT
Notice of effectiveness
3 May 12
EFFECT
Notice of effectiveness
3 May 12
EFFECT
Notice of effectiveness
3 May 12
POS AM
Prospectus update (post-effective amendment)
1 May 12
POS AM
Prospectus update (post-effective amendment)
1 May 12
POS AM
Prospectus update (post-effective amendment)
1 May 12
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 12
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 12
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 12
Latest ownership filings
SC 13D/A
GAMCO INVESTORS, INC. ET AL
24 Apr 12
SC 13D/A
GAMCO INVESTORS, INC. ET AL
17 Apr 12
SC 13D
GAMCO INVESTORS, INC. ET AL
30 Mar 12
11-K
Annual report of employee stock purchases
26 Jun 08
11-K
Annual report of employee stock purchases
15 Jun 07
11-K
Annual report of employee stock purchases
27 Jun 06
11-K/A
Annual report of employee stock purchases (amended)
16 Feb 06
11-K
Annual report of employee stock purchases
24 Jun 05
11-K
Annual report of employee stock purchases
24 Jun 04
11-K
Annual report of employee stock purchases
11 Jul 03